The genetic alteration belonging to the PI3K/AKT pathway promotes cell transformation from thyroid normal cells to FTC, while the genetic alteration of the MAPK pathway accelerates the transformation of cells to PTC. This evidence concerns the gene PIK3CB and thyroid cancer, nonmedullary, 2.